Status:
COMPLETED
Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies
Lead Sponsor:
Fytexia
Collaborating Sponsors:
Universidad Católica San Antonio de Murcia
Conditions:
Nutrition, Healthy
Eligibility:
All Genders
25-69 years
Phase:
NA
Brief Summary
The aim of this study is to investigate phenolic compounds from ESIT12, a poplar-type propolis ingredient, bioavailability and nutrikinetics by measuring urinary excretion and metabolic profile over 4...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Male and female with 40% min. and 60% max. of each sex.
- Aged 25 to 69 years old
- BMI range (18.5 - 29.99)
- In good general health as evidenced by medical history
- Ability to take oral supplementation and be willing to adhere to the regimen
- Agreement to adhere to Lifestyle Considerations (controlled diet) throughout study duration
Exclusion
- Current use of any medication or food supplement
- Antibiotic use less than 12 weeks before the study
- Pregnancy or lactation
- Known allergic reactions to components of the supplement, i.e., bee products (specially propolis) and known allergy (general)
- Metabolic disorders or any kind of disease
- Current smoker
Key Trial Info
Start Date :
July 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06062511
Start Date
July 22 2023
End Date
October 10 2023
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Católica San Antonio de Murcia
Guadalupe, Murcia, Spain, 30107